{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T03:06:33Z","timestamp":1776740793984,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clbc.2023.02.005","type":"journal-article","created":{"date-parts":[[2023,2,12]],"date-time":"2023-02-12T17:22:08Z","timestamp":1676222528000},"page":"e200-e205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Breast Cancer Screening Utilization and Outcomes in Women With Neurofibromatosis Type 1"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6125-2063","authenticated-orcid":false,"given":"Kevin","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha L.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.clbc.2023.02.005_bib0001","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.clbc.2023.02.005_bib0002","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"issue":"3 Pt 1","key":"10.1016\/j.clbc.2023.02.005_bib0003","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"issue":"8","key":"10.1016\/j.clbc.2023.02.005_bib0004","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0161-6420(84)34217-8","article-title":"von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata","volume":"91","author":"Lewis","year":"1984","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.clbc.2023.02.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0945","article-title":"Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020","volume":"4","author":"Landry","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2023.02.005_bib0006","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13053-019-0110-z","article-title":"Increased breast cancer risk in women with neurofibromatosis type 1: a meta-analysis and systematic review of the literature","volume":"17","author":"Suarez-Kelly","year":"2019","journal-title":"Hered Cancer Clin Pract"},{"issue":"5","key":"10.1016\/j.clbc.2023.02.005_bib0007","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"Rasmussen","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.clbc.2023.02.005_bib0008","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10549-018-4851-6","article-title":"Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype","volume":"171","author":"Yap","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.clbc.2023.02.005_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/bjc.2016.403","article-title":"Breast cancer in neurofibromatosis type 1: overrepresentation of unfavourable prognostic factors","volume":"116","author":"Uusitalo","year":"2017","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2023.02.005_bib0010","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/ajmg.a.35550","article-title":"Increased risk of breast cancer in women with NF1","volume":"158A","author":"Madanikia","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"8","key":"10.1016\/j.clbc.2023.02.005_bib0011","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/jmg.2007.049346","article-title":"Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening","volume":"44","author":"Sharif","year":"2007","journal-title":"J Med Genet"},{"issue":"12","key":"10.1016\/j.clbc.2023.02.005_bib0012","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/ajmg.a.35560","article-title":"Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area","volume":"158A","author":"Wang","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.clbc.2023.02.005_bib0013","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bjc.6603227","article-title":"A prospective study of neurofibromatosis type 1 cancer incidence in the UK","volume":"95","author":"Walker","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.02.005_bib0014","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clbc.2023.02.005_bib0015","series-title":"ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System","author":"D'Orsi","year":"2013"},{"issue":"3 Pt A","key":"10.1016\/j.clbc.2023.02.005_bib0016","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.clbc.2023.02.005_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1148\/radiol.2016161174","article-title":"National performance benchmarks for modern screening digital mammography: update from the breast cancer surveillance consortium","volume":"283","author":"Lehman","year":"2017","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.clbc.2023.02.005_bib0018","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10549-016-3748-5","article-title":"Adherence to the breast cancer surveillance program for women at risk for familial breast and ovarian cancer versus overscreening: a monocenter study in Germany","volume":"156","author":"Vetter","year":"2016","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clbc.2023.02.005_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050707","article-title":"NF1 patients receiving breast cancer screening: insights from the Ontario high risk breast screening program","volume":"11","author":"Maani","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"15_suppl","key":"10.1016\/j.clbc.2023.02.005_bib0020","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1200\/JCO.2019.37.15_suppl.1557","article-title":"Breast cancer screening adherence at multiple timepoints over eight years among women in a familial cohort","volume":"37","author":"Schaeffer","year":"2019","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.clbc.2023.02.005_bib0021","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/cncr.33140","article-title":"Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016","volume":"126","author":"Wernli","year":"2020","journal-title":"Cancer."},{"issue":"1","key":"10.1016\/j.clbc.2023.02.005_bib0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jbi\/wbab088","article-title":"Recent trends in screening breast MRI","volume":"4","author":"Lee","year":"2022","journal-title":"J Breast Imaging"},{"issue":"20","key":"10.1016\/j.clbc.2023.02.005_bib0023","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1001\/jama.295.20.2374","article-title":"Cost-effectiveness of screening BRCA1\/2 mutation carriers with breast magnetic resonance imaging","volume":"295","author":"Plevritis","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.clbc.2023.02.005_bib0024","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bjc.6603356","article-title":"Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer","volume":"95","author":"Griebsch","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.02.005_bib0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.rcl.2020.09.004","article-title":"Magnetic resonance imaging in screening of breast cancer","volume":"59","author":"Gao","year":"2021","journal-title":"Radiol Clin North Am"},{"issue":"2","key":"10.1016\/j.clbc.2023.02.005_bib0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s10689-021-00259-9","article-title":"The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1","volume":"21","author":"Crook","year":"2022","journal-title":"Fam Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2023.02.005_bib0027","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/gim.2012.85","article-title":"Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome","volume":"14","author":"Wang","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.clbc.2023.02.005_bib0028","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12885-015-1215-z","article-title":"Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas","volume":"15","author":"Da Silva","year":"2015","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2023.02.005_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.clbc.2011.07.005","article-title":"A hidden breast lump covered by nipple appendices in a patient with von Recklinghausen disease: a case report and review of the literature","volume":"12","author":"Zhou","year":"2012","journal-title":"Clin Breast Cancer"},{"issue":"21","key":"10.1016\/j.clbc.2023.02.005_bib0030","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1200\/JCO.2013.52.8331","article-title":"Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the Ontario high risk breast screening program","volume":"32","author":"Chiarelli","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.02.005_bib0031","first-page":"531","article-title":"Increased risk of breast cancer in neurofibromatosis type 1: current insights","volume":"9","author":"Howell","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:24:40Z","timestamp":1761513880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1526820923000356"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.02.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast Cancer Screening Utilization and Outcomes in Women With Neurofibromatosis Type 1","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}